This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity for July 2024. We discuss several US Department of Health and Human Services (HHS) agency actions, including a final rule on provider information blocking disincentives, a telehealth policy proposal from the Centers for Medicare & Medicaid Services (CMS), new CMS guidance for the Medicare Drug Payment Program, and the US Food and Drug Administration’s (FDA’s) new draft guidance on combating medical product misinformation. We also discuss two similar Office of Inspector General (OIG) advisory opinions and several enforcement actions pertaining to healthcare fraud, including alleged violations under the False Claims Act (FCA) and federal Anti-Kickback Statute (AKS).